Ilyang Pharm confirms effect of treating Parkinson’s disease treatment from leukemia treatment ‘Supect’

‘Radotinib(product name: Supect),’ a leukemia treatment developed by Ilyang Pharmaceutical, showed a clinical trial result that it had an effect of treating ‘Parkinson’s disease’ as well.

Ilyang Pharm announced on the 26th that a research team at Johns Hopkins University conducted mechanism, cell and animal studies for a year to figure out the radotinib’s effect of treating ‘Parkinson’s diseas...